Preliminary outcome of TransAtlantic’s rights issue

Preliminary outcome of TransAtlantic’s rights issue

This press release is not intended for distribution, publication or release,
directly or indirectly, into the United States, Australia, Canada, Hong Kong or
Japan.

The preliminary result of Rederi AB TransAtlantic's (“TransAtlantic”) rights
issue indicates that approximately 41 million shares, representing approximately
74 per cent of the offered shares, were subscribed for by the exercise of
subscription rights. Additionally, subscription applications corresponding to
approximately 17,500 shares have been received for subscription with subsidiary
preferential rights. The remaining approximately 14 million shares will be
subscribed for by Kistefos which has entered into a commitment to subscribe for
shares for up to 260 MSEK in addition to its pro rata-share. This means that the
rights issue will be fully subscribed. Through the rights issue, TransAtlantic
will receive proceeds amounting to approximately 555 MSEK before deduction of
transaction costs.

Those who have subscribed for shares with subsidiary preferential rights will be
allotted shares according to the principles outlined in the prospectus.
Subscribers who have been allotted shares on the basis of subsidiary
preferential rights are expected to be notified on or around 8 December 2011.
Only those who are allotted shares will be notified.

Through the rights issue TransAtlantic's share capital increases by 554,513,500
SEK to 1,109,027,000 SEK.[1] The number of shares increases by 55,451,350 of
which 3,635,921 shares of series A and 51,815,429 shares of series B. The total
number of shares after the rights issue amounts to 110,902,700 shares of which
7,271,842 shares of series A and 103,630,858 shares of series B.

The final day for trading in paid subscribed shares (BTAs) is expected to be 16
December 2011. New shares subscribed for by the exercise of subscription rights
are expected to start trading on NASDAQ OMX Stockholm on 19 December 2011.
Trading in shares subscribed with subsidiary preferential rights is expected to
start on 22 December 2011. Only shares of series B will be traded on NASDAQ OMX
Stockholm.

Göteborg, 6 December 2011

Rederi AB TransAtlantic (publ)

For additional informtion, please visit www.rabt.se or contact:
Rolf Skaarberg, Chief Executive Officer of TransAtlantic, or Gunnar Modalen,
Chief Financial Officer of TransAtlantic, tel +46 (0)304 67 47 00.

Rederi AB TransAtlantic (publ), org.nr. 556161-0113
Box 8809, 402 71 Göteborg
Tel +46 (0)304 67 47 00
www.rabt.se

TransAtlantic is obliged to make this information public according the Financial
Markets Act and the Financial Instruments Trading Act (Sw: lagen om
värdepappersmarknaden and lagen om handel med finansiella instrument). The
information was submitted for publication on 6th December 2011 at 08.30 a.m.

 
IMPORTANT INFORMATION
THIS PRESS RELEASE AND THE INFORMATION HEREIN MAY NOT, AS REGARDS THE
INFORMATION ON THE RIGHTS ISSUE DESCRIBED IN THE PRESS RELEASE, BE DISTRIBUTED,
PUBLISHED OR DISCLOSED, DIRECTLY OR INDIRECTLY, AND IS NOT DIRECTED TO PERSONS
IN OR WITH DOMICILE IN THE UNITED STATES, AUSTRALIA, CANADA, HONGKONG OR JAPAN,
OR ANY OTHER COUNTRY OR JURISDICTION WHERE IT IS NOT PERMITTED TO PURCHASE OR
SELL THE SUBSCRIPTION RIGHTS, THE SHARES OR PAID SUBSCRIBED SHARES, AND THE
INFORMATION MAY NOT BE REPRODUCED IN ANY WAY, PARTLY OR ENTIRELY.

The information on the rights issue in this press release is not an offer for
subscription for shares in TransAtlantic. A prospectus relating to the rights
issue referred to in this press release and the subsequent listing of the shares
at NASDAQ OMX Stockholm has been prepared and filed with the Swedish Financial
Supervisory Authority. After approval of the prospectus by the Swedish Financial
Supervisory Authority, the prospectus will be published and made available on
inter alia TransAtlantic’s website.

The distribution of this press release in certain jurisdictions may be
restricted by law and persons into whose possession it or any part of it comes
should inform themselves about and observe any such restrictions. The
information in this press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of the securities
referred to herein in any jurisdiction in which such offer, solicitation or sale
would require preparation of further prospectuses or other offer documentation,
or be unlawful prior to registration, exemption from registration or
qualification under the securities laws of any such jurisdiction.

This press release does not constitute, nor is it a part of, an offer to the
public or anyone else, or a solicitation of an offer to buy or subscribe for
securities in the United States. None of the securities mentioned in the press
release have been, nor will they be, registered under the United States
Securities Act of 1933, as amended (the “Securities Act”), or in any other
jurisdiction outside Sweden. Securities may not, in the absence of such
registration, be offered or transferred in or into the United States or to “U.S.
Persons” (as defined in Regulation S under the Securities Act) except pursuant
to an exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act.

This press release has not been approved by any authority. This press release is
not a prospectus and investors should not subscribe for or purchase securities
referred to in this press release, except on information in the prospectus
published on TransAtlantic’s website in due order.

---------------------------------------------------------------------r

[1] The Extraordinary General Meeting on 7 November 2011 adopted the decision to
reduce the company’s share capital. The reduction will take place after the
rights issue has been registered and will result in a share capital of SEK
110,902,700. The implementation of the decision on reduction is conditional upon
approval by the Swedish Companies Registration Office or, in the event of
dispute, from the District Court. Approval is expected at the end of February
2012.